Experts urge patience with vaccine strategy, expect rollout to gain steam soon


The United States' coronavirus vaccine rollout failed to meet the goal of inoculating 20 million people against COVID-19 by the end of 2020. Instead, more than four million have reportedly been vaccinated so far. That's sparked significant criticism about the pacing of the strategy while the coronavirus continues to surge across the country.
There have indeed been distribution and administration hiccups at the federal, state, and local levels for a variety of reasons like weather or the holiday season, as well as some unforeseen events, like a pharmacist deliberately removing hundreds of doses from storage, spoiling them in the process. Despite the bumpy road, however, experts are urging patience. Nancy Messionier, the director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention, believes vaccination numbers are going to pick up steam as soon as next week. Zoë McLaren, a professor at the University of Maryland, Baltimore County, School of Public Policy concurred, likening the plan to the "soft opening" of a restaurant.
Juliette Kayyem, a professor at Harvard's Kennedy School of Government, said "the anger and frustration" about the slower-than-expected start is "fair," but she also agrees with Messionier and McLaren and warned against people tinkering with the plans too soon, especially if that means resorting to "wild proposals" to get more people vaccinated. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How will Trump's megabill affect you?
Today's Big Question Republicans have passed the 'big, beautiful bill' through Congress
-
Scientists are the latest 'refugees'
In the spotlight Brain drain to brain gain
-
5 dreamy books to dive into this July
The Week Recommends A 'politically charged' collection of essays, historical fiction goes sci-fi and more
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia